TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancersTushar D. Nichakawade, Suman Paul, Brian J. Mog et al.|Nature|2024Cited by 43
NXPE1 alters the sialoglycome by acetylating sialic acids in the human colonBum Seok Lee, Nicolas Wyhs|Nature Communications|2025Cited by 2
TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancersJiaxin Ge, Stephanie Glavaris, X. Li et al.|Nature Cancer|2025Cited by 1
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLNour Sabiha Naji, Theodoros Karantanos, Evangeline Watson et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Suman Paul, Evangeline Watson et al.|Research Square|2025Cited by 0